A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms

Myeloproliferative neoplasms are a varied group of disorders that can have prolonged chronic phases, but eventually accelerate and can transform into a secondary acute myeloid leukemia that is ultimately fatal. Triapine is a novel inhibitor of the M2 subunit of ribonucleotide reductase. Sequential i...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Zeidner, Joshua F., Karp, Judith E., Blackford, Amanda L., Smith, B. Douglas, Gojo, Ivana, Gore, Steven D., Levis, Mark J., Carraway, Hetty E., Greer, Jacqueline M., Ivy, S. Percy, Pratz, Keith W., McDevitt, Michael A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ferrata Storti Foundation 2014
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3971077/
https://ncbi.nlm.nih.gov/pubmed/24362550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.097246
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller